Greater treatment satisfaction in patients receiving daratumumab subcutaneous vs. intravenous for relapsed or refractory multiple myeloma: COLUMBA clinical trial results

Saad Z. Usmani; Maria Victoria Mateos; Vania Hungria; Shinsuke Iida; Nizar J. Bahlis; Hareth Nahi; Hila Magen; Michele Cavo; Cyrille Hulin; Darrell White; Valerio De Stefano; John Fastenau; Mary Slavcev; Christoph Heuck; Xiang Qin; Huiling Pei; Tara Masterson; Kristen Lantz; Katharine S. Gries

doi:10.1007/s00432-020-03365-w

Greater treatment satisfaction in patients receiving daratumumab subcutaneous vs. intravenous for relapsed or refractory multiple myeloma: COLUMBA clinical trial results

Saad Z. Usmani, Maria Victoria Mateos, Vania Hungria, Shinsuke Iida, Nizar J. Bahlis, Hareth Nahi, Hila Magen, Michele Cavo, Cyrille Hulin, Darrell White, Valerio De Stefano, John Fastenau, Mary Slavcev, Christoph Heuck, Xiang Qin, Huiling Pei, Tara Masterson, Kristen Lantz, Katharine S. Gries

Research output: Contribution to journal › Article › peer-review

23 Citations (Scopus)

Original language	English
Pages (from-to)	619-631
Number of pages	13
Journal	Journal of Cancer Research and Clinical Oncology
Volume	147
Issue number	2
DOIs	https://doi.org/10.1007/s00432-020-03365-w
Publication status	Published - Feb 2021
Externally published	Yes

ASJC Scopus Subject Areas

Oncology
Cancer Research

Keywords

Daratumumab
Patient satisfaction
Patient-reported outcomes
Relapsed/refractory multiple myeloma
Subcutaneous

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/s00432-020-03365-w

Cite this

Usmani, S. Z., Mateos, M. V., Hungria, V., Iida, S., Bahlis, N. J., Nahi, H., Magen, H., Cavo, M., Hulin, C., White, D., De Stefano, V., Fastenau, J., Slavcev, M., Heuck, C., Qin, X., Pei, H., Masterson, T., Lantz, K., & Gries, K. S. (2021). Greater treatment satisfaction in patients receiving daratumumab subcutaneous vs. intravenous for relapsed or refractory multiple myeloma: COLUMBA clinical trial results. Journal of Cancer Research and Clinical Oncology, 147(2), 619-631. https://doi.org/10.1007/s00432-020-03365-w

Greater treatment satisfaction in patients receiving daratumumab subcutaneous vs. intravenous for relapsed or refractory multiple myeloma: COLUMBA clinical trial results. / Usmani, Saad Z.; Mateos, Maria Victoria; Hungria, Vania et al.
In: Journal of Cancer Research and Clinical Oncology, Vol. 147, No. 2, 02.2021, p. 619-631.

Research output: Contribution to journal › Article › peer-review

Usmani, SZ, Mateos, MV, Hungria, V, Iida, S, Bahlis, NJ, Nahi, H, Magen, H, Cavo, M, Hulin, C, White, D, De Stefano, V, Fastenau, J, Slavcev, M, Heuck, C, Qin, X, Pei, H, Masterson, T, Lantz, K & Gries, KS 2021, 'Greater treatment satisfaction in patients receiving daratumumab subcutaneous vs. intravenous for relapsed or refractory multiple myeloma: COLUMBA clinical trial results', Journal of Cancer Research and Clinical Oncology, vol. 147, no. 2, pp. 619-631. https://doi.org/10.1007/s00432-020-03365-w

@article{8deffd0a8d2641f9898c71d59d535507,

title = "Greater treatment satisfaction in patients receiving daratumumab subcutaneous vs. intravenous for relapsed or refractory multiple myeloma: COLUMBA clinical trial results",

keywords = "Daratumumab, Patient satisfaction, Patient-reported outcomes, Relapsed/refractory multiple myeloma, Subcutaneous",

author = "Usmani, {Saad Z.} and Mateos, {Maria Victoria} and Vania Hungria and Shinsuke Iida and Bahlis, {Nizar J.} and Hareth Nahi and Hila Magen and Michele Cavo and Cyrille Hulin and Darrell White and {De Stefano}, Valerio and John Fastenau and Mary Slavcev and Christoph Heuck and Xiang Qin and Huiling Pei and Tara Masterson and Kristen Lantz and Gries, {Katharine S.}",

note = "Publisher Copyright: {\textcopyright} 2020, Springer-Verlag GmbH Germany, part of Springer Nature.",

year = "2021",

month = feb,

doi = "10.1007/s00432-020-03365-w",

language = "English",

volume = "147",

pages = "619--631",

journal = "Journal of Cancer Research and Clinical Oncology",

issn = "0171-5216",

publisher = "Springer Verlag",

number = "2",

}

TY - JOUR

T1 - Greater treatment satisfaction in patients receiving daratumumab subcutaneous vs. intravenous for relapsed or refractory multiple myeloma

T2 - COLUMBA clinical trial results

AU - Usmani, Saad Z.

AU - Mateos, Maria Victoria

AU - Hungria, Vania

AU - Iida, Shinsuke

AU - Bahlis, Nizar J.

AU - Nahi, Hareth

AU - Magen, Hila

AU - Cavo, Michele

AU - Hulin, Cyrille

AU - White, Darrell

AU - De Stefano, Valerio

AU - Fastenau, John

AU - Slavcev, Mary

AU - Heuck, Christoph

AU - Qin, Xiang

AU - Pei, Huiling

AU - Masterson, Tara

AU - Lantz, Kristen

AU - Gries, Katharine S.

PY - 2021/2

Y1 - 2021/2

KW - Daratumumab

KW - Patient satisfaction

KW - Patient-reported outcomes

KW - Relapsed/refractory multiple myeloma

KW - Subcutaneous

UR - http://www.scopus.com/inward/record.url?scp=85089920581&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85089920581&partnerID=8YFLogxK

U2 - 10.1007/s00432-020-03365-w

DO - 10.1007/s00432-020-03365-w

M3 - Article

C2 - 32852632

AN - SCOPUS:85089920581

SN - 0171-5216

VL - 147

SP - 619

EP - 631

JO - Journal of Cancer Research and Clinical Oncology

JF - Journal of Cancer Research and Clinical Oncology

IS - 2

ER -

Greater treatment satisfaction in patients receiving daratumumab subcutaneous vs. intravenous for relapsed or refractory multiple myeloma: COLUMBA clinical trial results

ASJC Scopus Subject Areas

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this